Valganciclovir should be used with caution and these situations should be avoided!

Valganciclovir , chemically named Valganciclovir, is an antiviral drug widely used to prevent and treat cytomegalovirus (CMV) infection. Despite its effectiveness, use of valganciclovir may pose risks in certain circumstances. Next, let’s take a closer look at the circumstances under which Valganciclovir (valganciclovir) should be avoided or used with caution.

1. There is an allergic reaction

If a patient has had an allergic reaction to Valganciclovir or its similar drug, galcyclovir, re-use of Valganciclovir is strictly contraindicated. Symptoms of an allergic reaction may include skin rash, hives, intense itching, and even difficulty breathing. In extreme cases, a severe allergic reaction can lead to anaphylactic shock, a life-threatening condition that requires the medication to be stopped immediately and emergency medical attention must be sought.

2. Impaired kidney function

Since Valganciclovir is mainly excreted through the kidneys, for patients with significantly reduced renal function, the use of Valganciclovir may increase the burden on the kidneys. Renal insufficiency may cause drugs to accumulate in the body, which increases the risk of drug side effects and may even trigger nephrotoxic reactions. Therefore, such patients must consult their doctor before taking medication.

3. In pregnancy or lactation period

Regarding the safety of Valganciclovir to fetuses and newborns, scientific research has not yet reached a clear conclusion. Therefore, caution is required when using valganciclovir in women who are pregnant or breastfeeding. The use of valganciclovir during this time should be avoided unless under the explicit advice of your doctor and the potential therapeutic benefits clearly outweigh the potential risks. Breastfeeding women also need to weigh the pros and cons of breastfeeding versus medication.

4. Suffering from certain blood diseases

Hematological diseases such as bone marrow suppression, granulocytopenia or thrombocytopenia may affect a patient's tolerance to Valganciclovir. Valganciclovir may further inhibit the patient's hematopoietic system, thereby aggravating the symptoms of existing blood diseases, and even leading to serious problems such as bleeding tendency or susceptibility to infection.

5. Liver insufficiency

Special caution is also required when using Valganciclovir in patients with significant liver function abnormalities. Because Valganciclovir undergoes some metabolic processes in the liver, hepatic insufficiency may affect the normal metabolism and excretion of the drug, causing the drug to stay in the body for too long, thereby increasing the risk of adverse reactions.

6. Are using other antiviral drugs

If the patient is taking other antiviral drugs, such as acyclovir, extra caution is required when using Valganciclovir. Because the simultaneous use of multiple antiviral drugs may increase the chance of adverse reactions. In this case, the patient should follow the doctor's advice to adjust the drug dosage and medication time.

In summary, although Valganciclovir is an effective antiviral drug, it needs to be used with extreme caution or avoided entirely in the specific situations described above. Before starting to use Valganciclovir, patients should fully communicate with their doctors and inform them in detail of their medical history and current health status to ensure the safety and effectiveness of the medication.